A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the onset and duration of action of AC-170 0.24%
compared to vehicle in the prevention of the signs and symptoms of allergic conjunctivitis in
the conjunctival allergen challenge (CAC) model.